AARP Continues Nationwide Assault on High Drug Prices; 'Watchdog'Study Finds Soaring Rx Prices; Drug Affordability a Top StatePriority for AARP New York

ALBANY, N.Y., Nov. 2 /U.S. Newswire/ -- A new prescription drug price report issued by AARP today found that the manufacturer prices for brand name prescription drugs continue to rise at an average rate that greatly outpaces general inflation. The Rx Watchdog Study found prices for nearly 200 of the most commonly used brand name drugs rose 6.1 percent over the course of a 12-month period, while the rate of inflation increased by just 3 percent.

"State, federal and family health care budgets are being stretched to the max, and sadly sometimes beyond," said Bill Novelli, AARP CEO. ...

Read the rest of this article with a Free Trial at HighBeam Research.